Short Sellers Raise the Stakes in Major Biotechs
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all should be solid additions to growth portfolios for 2019.
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination regimens in multiple cancer settings.
Four states have marijuana legalization efforts of sorts up for grabs on Tuesday, November 6, 2018. Here is some basic information on the efforts.
Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.
Regulus Therapeutics shares shot up on Tuesday after the company announced that it had amended and restructured its collaboration and license agreement with Sanofi.
CVS reported third-quarter results Tuesday morning that beat estimates on both the top and bottom lines. The company also said it expects to close its acquisition of Aetna by Thanksgiving.
Mylan reported better-than-expected quarterly results late Monday, and shares rose sharply in Friday's premarket.
Medical technology company Vapotherm intends to price 4 million shares for and initial public offering valued up to more than $73 million.
Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.
Clearside Biomedical shares were halved early on Monday after the firm reported results from its late-stage Sapphire trial.
AbbVie released its third quarter financial results before the markets opened on Friday. The pharma giant said that it had $2.14 in earnings per share (EPS) and $8.24 billion in revenue, compared with consensus…
Alkermes shares dropped early on Friday after the company anncounced the results from its most recent meeting with the U.S. Food and Drug Administration.
Teva Pharmaceutical released its most recent earnings report before the markets opened on Thursday.